NYTTHÅP HOLDING AS
Behandling alkoholproblemer, pillemisbruk, utbrenthet på Kildevangen
Behandling alkoholproblemer, pillemisbruk, utbrenthet, rusmisbruk på Kildevangen. Individuell terapi. Privat, liten klinikk med full anonymitet. Enerom.
Keywords
inpatient facilitiesinpatient wardsinterdisciplinaryaddiction treatment
Links
Organization
- CEO
- RG
Roger Granberg1965
- Chairman of the board
- RG
Roger Granberg1965
- Years since formation
- 12 years
- since Jun 19, 2012
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 44
- 1 share class
- Total number of shareholders
- 2
- persons
- Belongs to group of
Financials
- Annual total result 2023
- -62,110
- NOK
- Total equity 2023
- -404,786
- NOK
Last update: Dec 11, 2024
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
RG 1965 | Managing Director/CEO | 50 % directly |
Board
| Name | Role | Shares |
|---|---|---|
RG 1965 | Chairman | 50 % directly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
RG 1965 | Managing Director/CEO, Chairman | 50 % directly |
SB | - | 50 % directly |
Last update: Jul 10, 2024
Ownership
Company shareholders
| Name | Share class | Number of shares | Share |
|---|---|---|---|
RG 1965 | Ordinary shares | 22 | 50 % |
SB | Ordinary shares | 22 | 50 % |
Shares owned by the NYTTHÅP HOLDING AS
| Name | Share class | Number of shares | Share |
|---|---|---|---|
| Ordinary shares | 100 | 100 % | |
| Ordinary shares | 30,000 | 100 % |
Last update: May 24, 2024
Group structure
- Total operating income 2023: NOK 0Operating profit 2023: NOK -61,811Employees: 0
Financials
in NOK
Summary
| Year | 2023 | 2022 |
|---|---|---|
Total operating income | 0 | 1,560,000 |
Annual Total Result | -62,110 | 2,193,891 |
Total assets | 838,190 | 6,779,917 |
Total liabilities | 1,242,976 | 6,130,486 |
Total equity | -404,786 | 649,431 |
P&L
| Year | 2023 | 2022 |
|---|---|---|
Total operating income | 0 | 1,560,000 |
Total operating costs | 61,811 | 394,562 |
Operating result | -61,811 | 1,165,438 |
Financial income/costs | -299 | 1,252,455 |
Profit before tax | -62,110 | 2,417,893 |
Total tax & extraordinary income/cost | 0 | 224,002 |
Annual Total Result | -62,110 | 2,193,891 |
Balance overview
| Year | 2023 | 2022 |
|---|---|---|
Total fixed assets | 60,000 | 4,897,000 |
Total current assets | 778,190 | 1,882,917 |
Total assets | 838,190 | 6,779,917 |
Short term debt | 1,242,976 | 2,252,023 |
Long term debt | 0 | 3,878,463 |
Total liabilities | 1,242,976 | 6,130,486 |
Contributed capital | 44,000 | 32,000 |
Retained earnings | -448,786 | 617,431 |
Total equity | -404,786 | 649,431 |
Total equity and liabilities | 838,190 | 6,779,917 |
Classification
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
Q
Main industrial area
Human health and social work activities
86
Activity
Human health activities
86.1
Main industrial group
Hospital activities
86.10
Industrial group
Hospital activities
86.106
Industrial group
Drug treatment units within specialist health services